Evidence map›Paper›PMID 41227951›Full record

ArticleMaterials (Basel, Switzerland)2025

Effect of Antimicrobial Filler on Ethylene-Vinyl Acetate (EVA) Composites Property.

Kamil Kwieciński, Marta Chrószcz-Porębska, Izabela Barszczewska-Rybarek, Jarosław Żmudzki, Anna Mertas, Sebastian Jurczyk, Paweł Popielski, Grzegorz Chladek

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kamil KwiecińskiApipharma Sp. z o. o., 44/7 Kościuszki Str., 40-040 Katowice, Poland.ORCID 0009-0004-5066-2085
Marta Chrószcz-PorębskaChair of Drug and Cosmetics Biotechnology, Faculty of Chemistry, Warsaw University of Technology, 3 Noakowskiego Str., 00-664 Warsaw, Poland.ORCID 0000-0001-6978-2547
Izabela Barszczewska-RybarekDepartment of Physical Chemistry and Technology of Polymers, Faculty of Chemistry, Silesian University of Technology, Strzody 9 Str., 44-100 Gliwice, Poland.ORCID 0000-0002-2708-1854
Jarosław ŻmudzkiDepartment of Engineering Materials and Biomaterials, Faculty of Mechanical Engineering, Silesian University of Technology, 18a Konarskiego Str., 41-100 Gliwice, Poland.ORCID 0000-0003-1044-2358
Anna MertasDepartment of Microbiology and Immunology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 19 Jordana Str., 41-808 Zabrze, Poland.ORCID 0000-0003-0796-8818
Sebastian JurczykŁukasiewicz Research Network-Institute of Polymer Materials, 55 Skłodowskiej-Curie Str., 87-100 Torun, Poland.ORCID 0000-0003-4179-0558
Paweł PopielskiInstitute of Biomedical Engineering, University of Silesia in Katowice, 39 Będzińska Str., 41-200 Sosnowiec, Poland.ORCID 0000-0001-5189-732X
Grzegorz ChladekMaterials Research Laboratory, Faculty of Mechanical Engineering, Silesian University of Technology, 18a Konarskiego Str., 41-100 Gliwice, Poland.ORCID 0000-0001-8282-4131

Funding

Silesian University of Technology 10/100/RGJ25/0104
6 · The paper itself

Abstract

Ethylene-vinyl acetate (EVA) is a versatile polymer for applications in dental devices; however, its vulnerability to microbial colonization increases with long-term use. This study evaluates EVA composites modified with silver-sodium-hydrogen-zirconium phosphate (SP) particles, aimed at enhancing antimicrobial performance while preserving key functional properties. Composites containing 1-16 wt.% SP were prepared via solvent-based and mechanical compounding routes, with scanning electron microscopy confirming correct filler distribution across processing methods. Antimicrobial assays revealed a pronounced reduction in

Indexed as

antimicrobialCandidacompositescytotoxicityethylene–vinyl acetate (EVA)mechanical propertiesparticlessilverwettability

Identifiers

PMID41227951
PMCPMC12608532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.